Improving survival for patients with advanced heart failure: a study of 737 consecutive patients

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

OBJECTIVES: This study sought to determine whether survival and risk of sudden death have improved for patients with advanced heart failure referred for consideration for heart transplantation as advances in medical therapy were systematically implemented over an 8-year period. BACKGROUND: Recent survival trials in patients with mild to moderate heart failure and patients after a myocardial infarction have shown that angiotensin-converting enzyme inhibitors are beneficial, type I antiarrhythmic drugs can be detrimental, and amiodarone may be beneficial in some groups. The impact of advances in therapy may be enhanced or blunted when applied to severe heart failure. METHODS: One-year mortality and sudden death were determined in relation to time, baseline variables and therapeutics for 737 consecutive patients referred for heart transplantation and discharged home on medical therapy from 1986 to 1988, 1989 to 1990 and 1991 to 1993. Medical care was directed by a single team of physicians with policies established by consensus. From 1986 to 1990, the hydralazine/isosorbide dinitrate combination or angiotensin-converting enzyme inhibitors were the initial vasodilators, and class I antiarrhythmic drugs were allowed. After 1990, captopril was the initial vasodilator, given to 86% of patients compared with 46% of patients before 1989. After mid-1989, class I agents were routinely withdrawn, and amiodarone was used for frequent ventricular ectopic beats or atrial fibrillation (53% of patients after 1990 vs. 10% before 1989). RESULTS: The total 1-year mortality rate decreased from 33% before 1989 to 16% after 1990 (p = 0.0001), and sudden death decreased from 20% to 8% (p = 0.0006). Adjusted for clinical and hemodynamic variables in multivariate proportional hazards models, total mortality and sudden death were lower after 1990. CONCLUSIONS: The large reduction in mortality, particularly in sudden death, from advanced heart failure since 1990 may reflect an enhanced impact of therapeutic advances shown in large randomized trials when they are incorporated into a comprehensive approach in this population. This improved survival supports the growing practice of maintaining potential heart transplant candidates on optimal medical therapy until clinical decompensation mandates transplantation.

This article has been cited by other articles:

				P A Mehta, S W Dubrey, H F McIntyre, D M Walker, S M C Hardman, G C Sutton, T A McDonagh, and M. R Cowie Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK Heart, November 15, 2009; 95(22): 1851 - 1856. [Abstract] [Full Text] [PDF]

				A. P. Maggioni, G. Fabbri, D. Lucci, R. Marchioli, M. G. Franzosi, R. Latini, G. L. Nicolosi, M. Porcu, F. Cosmi, S. Stefanelli, et al. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial Eur. Heart J., October 1, 2009; 30(19): 2327 - 2336. [Abstract] [Full Text] [PDF]

				M. A. Castel, F. Mendez, D. Tamborero, L. Mont, S. Magnani, J. M. Tolosana, A. Berruezo, M. Godoy, M. Sitges, B. Vidal, et al. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy Europace, March 1, 2009; 11(3): 338 - 342. [Abstract] [Full Text] [PDF]

				W. Mullens, A. G. Borowski, R. J. Curtin, J. D. Thomas, and W.H. Tang Tissue Doppler Imaging in the Estimation of Intracardiac Filling Pressure in Decompensated Patients With Advanced Systolic Heart Failure Circulation, January 6, 2009; 119(1): 62 - 70. [Abstract] [Full Text] [PDF]

				M. Rivero-Ayerza, W. Scholte op Reimer, M. Lenzen, D. A.M.J. Theuns, L. Jordaens, M. Komajda, F. Follath, K. Swedberg, and J. G.F. Cleland New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey Eur. Heart J., July 1, 2008; 29(13): 1618 - 1624. [Abstract] [Full Text] [PDF]

				L. G. Olsson, K. Swedberg, A. Ducharme, C. B. Granger, E. L. Michelson, J. J.V. McMurray, M. Puu, S. Yusuf, M. A. Pfeffer, and on behalf of the CHARM Investigators Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction: Results From the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) Program J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1997 - 2004. [Abstract] [Full Text] [PDF]

				C. H.M. van Jaarsveld, A. V. Ranchor, G. I.J.M. Kempen, J. C. Coyne, D. J. van Veldhuisen, and R. Sanderman Epidemiology of heart failure in a community-based study of subjects aged >=57 years: Incidence and long-term survival Eur J Heart Fail, January 1, 2006; 8(1): 23 - 30. [Abstract] [Full Text] [PDF]

				K. Swedberg, L. G. Olsson, A. Charlesworth, J. Cleland, P. Hanrath, M. Komajda, M. Metra, C. Torp-Pedersen, and P. Poole-Wilson Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET Eur. Heart J., July 1, 2005; 26(13): 1303 - 1308. [Abstract] [Full Text] [PDF]

				M. E. Ochiai, A. C.P. Barretto, M. T. Oliveira Jr., R. T. Munhoz, P. C. Morgado, and J. A.F. Ramires Uric acid renal excretion and renal insufficiency in decompensated severe heart failure Eur J Heart Fail, June 1, 2005; 7(4): 468 - 474. [Abstract] [Full Text] [PDF]

				J. L. Navia, F. A. Atik, R. A. Grimm, M. Garcia, P. R. Vega, U. Myhre, R. C. Starling, B. L. Wilkoff, D. Martin, P. L. Houghtaling, et al. Minimally Invasive Left Ventricular Epicardial Lead Placement: Surgical Techniques for Heart Failure Resynchronization Therapy Ann. Thorac. Surg., May 1, 2005; 79(5): 1536 - 1544. [Abstract] [Full Text] [PDF]

				M. Petersson, P. Friberg, G. Eisenhofer, G. Lambert, and B. Rundqvist Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure Eur. Heart J., May 1, 2005; 26(9): 906 - 913. [Abstract] [Full Text] [PDF]

				V. L. Roger, S. A. Weston, M. M. Redfield, J. P. Hellermann-Homan, J. Killian, B. P. Yawn, and S. J. Jacobsen Trends in Heart Failure Incidence and Survival in a Community-Based Population JAMA, July 21, 2004; 292(3): 344 - 350. [Abstract] [Full Text] [PDF]

				J. A. Morgan, R. John, V. Rao, A. D. Weinberg, B. J. Lee, P. A. Mazzeo, M. R. Flannery, J. M. Chen, M. C. Oz, and Y. Naka Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1309 - 1316. [Abstract] [Full Text] [PDF]

				D. M. Roden A Surprising New Arrhythmia Mechanism in Heart Failure Circ. Res., October 3, 2003; 93(7): 589 - 591. [Full Text] [PDF]

				O. Baron, A. Le Guyader, J. N. Trochu, M. Burban, J. C. Chevalier, M. Treilhaud, T. Petit, O. Al Habash, P. Despins, J. L. Michaud, et al. Does the pretransplant UNOS status modify the short- and long-term cardiac transplant prognosis? Ann. Thorac. Surg., June 1, 2003; 75(6): 1878 - 1885. [Abstract] [Full Text] [PDF]

				F. Gustafsson, C. Torp-Pedersen, B. Brendorp, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function Eur. Heart J., May 1, 2003; 24(9): 863 - 870. [Abstract] [Full Text] [PDF]

				T. Omoto, B. Hansky, K. Minami, J. Vogt, B. Lamp, and R. Korfer Successful bridging by biventricular pacing for heart transplantation Ann. Thorac. Surg., November 1, 2002; 74(5): 1684 - 1685. [Abstract] [Full Text] [PDF]

				D. Levy, S. Kenchaiah, M. G. Larson, E. J. Benjamin, M. J. Kupka, K. K.L. Ho, J. M. Murabito, and R. S. Vasan Long-Term Trends in the Incidence of and Survival with Heart Failure N. Engl. J. Med., October 31, 2002; 347(18): 1397 - 1402. [Abstract] [Full Text] [PDF]

				M. R. Cowie, K. F. Fox, D. A. Wood, C. Metcalfe, S. G. Thompson, A. J. S. Coats, P. A. Poole-Wilson, and G. C. Sutton Hospitalization of patients with heart failure. A population-based study Eur. Heart J., June 1, 2002; 23(11): 877 - 885. [Abstract] [Full Text] [PDF]

				C A Rinaldi, C A Bucknall, and J S Gill Beneficial effects of biventricular pacing in a patient with hypertrophic cardiomyopathy and intraventricular conduction delay Heart, June 1, 2002; 87(6): e6 - 6. [Abstract] [Full Text] [PDF]

				R.G Charles Cardiac resynchronization therapy: when and for whom? Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D117 - D121. [Abstract] [PDF]

				A. Nohria, E. Lewis, and L. W. Stevenson Medical Management of Advanced Heart Failure JAMA, February 6, 2002; 287(5): 628 - 640. [Abstract] [Full Text] [PDF]

				S. Cazeau, C. Leclercq, T. Lavergne, S. Walker, C. Varma, C. Linde, S. Garrigue, L. Kappenberger, G. A. Haywood, M. Santini, et al. Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay N. Engl. J. Med., March 22, 2001; 344(12): 873 - 880. [Abstract] [Full Text] [PDF]

				J. N. Nanas, G. Alexopoulos, M. I. Anastasiou-Nana, K. Karidis, A. Tirologos, S. Zobolos, V. Pirgakis, L. Anthopoulos, D. Sideris, S. F. Stamatelopoulos, et al. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2090 - 2095. [Abstract] [Full Text] [PDF]

				F. Braunschweig, C. Linde, F. Gadler, and L. Ryden Reduction of hospital days by biventricular pacing Eur J Heart Fail, December 1, 2000; 2(4): 399 - 406. [Abstract] [Full Text] [PDF]

				C. LINDE Biventricular pacing in patients with severe heart failure: has the time come? Heart, August 1, 2000; 84(2): 123 - 124. [Full Text] [PDF]

				M. Debrunner, B. Naegeli, and O. Bertel The Acute Effects of Transvenous Biventricular Pacing in a Patient With Congestive Heart Failure Chest, June 1, 2000; 117(6): 1798 - 1800. [Abstract] [Full Text] [PDF]

				M. Poullis Vasodilatation after cardiac surgery J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 857 - 857. [Full Text]

				P S Macdonald, A M Keogh, C Aboyoun, M Lund, R Amor, and D McCaffrey Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure Heart, November 1, 1999; 82(5): 589 - 593. [Abstract] [Full Text]

				L. W. Stevenson Tailored therapy to hemodynamic goals for advanced heart failure Eur J Heart Fail, August 31, 1999; 1(3): 251 - 257. [Full Text] [PDF]

				B.A. Bart, G. Ertl, P. Held, J. Kuch, A.P. Maggioni, J. McMurray, E.L. Michelson, J.L. Rouleau, L. Warner Stevenson, K. Swedberg, et al. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry Eur. Heart J., August 2, 1999; 20(16): 1182 - 1190. [Abstract] [PDF]

				R. S. Vasan, M. G. Larson, E. J. Benjamin, J. C. Evans, C. K. Reiss, and D. Levy Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1948 - 1955. [Abstract] [Full Text] [PDF]

				D.J. van Veldhuisen, A. Charlesworth, H.J.G.M. Crijns, K.I. Lie, and J.R. Hampton Differences in drug treatment of chronic heart failure between European countries Eur. Heart J., May 1, 1999; 20(9): 666 - 672. [Abstract] [PDF]

				H. P. Brunner-La Rocca, G. Vaddadi, and M. D. Esler Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1163 - 1173. [Abstract] [Full Text] [PDF]

				F. Zannad, S. Briancon, Y. Juilliere, P.-M. Mertes, J.-P. Villemot, F. Alla, J.-M. Virion, and and the EPICAL Investigators Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study J. Am. Coll. Cardiol., March 1, 1999; 33(3): 734 - 742. [Abstract] [Full Text] [PDF]

				S. Stewart, A. J. Vandenbroek, S. Pearson, and J. D. Horowitz Prolonged Beneficial Effects of a Home-Based Intervention on Unplanned Readmissions and Mortality Among Patients With Congestive Heart Failure Arch Intern Med, February 8, 1999; 159(3): 257 - 261. [Abstract] [Full Text] [PDF]

				C. Leclercq, S. Cazeau, H. Le Breton, P. Ritter, P. Mabo, D. Gras, D. Pavin, A. Lazarus, and J.-C. Daubert Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1825 - 1831. [Abstract] [Full Text] [PDF]

				R. Wang, M. Mouliswar, S. Denman, and M. Kleban Mortality of the Institutionalized Old-Old Hospitalized With Congestive Heart Failure Arch Intern Med, December 1, 1998; 158(22): 2464 - 2468. [Abstract] [Full Text] [PDF]

				S. A. Hunt Current Status of Cardiac Transplantation JAMA, November 18, 1998; 280(19): 1692 - 1698. [Abstract] [Full Text] [PDF]

				E. P. Havranek, F. Abrams, E. Stevens, and K. Parker Determinants of Mortality in Elderly Patients With Heart Failure: The Role of Angiotensin-Converting Enzyme Inhibitors Arch Intern Med, October 12, 1998; 158(18): 2024 - 2028. [Abstract] [Full Text] [PDF]

				M. L. Dickstein Anesthesia for Heart Transplantation Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1998; 2(2): 131 - 139. [Abstract] [PDF]

				S. Stewart, S. Pearson, and J. D. Horowitz Effects of a Home-Based Intervention Among Patients With Congestive Heart Failure Discharged From Acute Hospital Care Arch Intern Med, May 25, 1998; 158(10): 1067 - 1072. [Abstract] [Full Text] [PDF]

				M. Gheorghiade and R. O. Bonow Chronic Heart Failure in the United States : A Manifestation of Coronary Artery Disease Circulation, January 27, 1998; 97(3): 282 - 289. [Full Text] [PDF]

				R. J. Goldberg and T. E. Meyer Advances and Stagnations in Heart Failure Arch Intern Med, January 13, 1997; 157(1): 17 - 19. [Abstract] [PDF]

				J. M. Gore and J. E. Dalen Cardiovascular Disease JAMA, June 19, 1996; 275(23): 1797 - 1798. [Abstract] [PDF]

				T. P. Cappola, G. M. Felker, W.H. L. Kao, J. M. Hare, K. L. Baughman, and E. K. Kasper Pulmonary Hypertension and Risk of Death in Cardiomyopathy: Patients With Myocarditis Are at Higher Risk Circulation, April 9, 2002; 105(14): 1663 - 1668. [Abstract] [Full Text] [PDF]